GLP-1 receptor agonist use rises among children with obesity
Report says prescribing of the weight-loss drug class is increasing in pediatric patients.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 16 00:00 ETSource: Ophthalmology Advisor
The wire
- 01Coverage reports growing use of GLP-1 receptor agonists among children with obesity.
- 02Expanding pediatric use raises long-term safety and monitoring questions.
- 03The item does not provide prescription volumes, time period or data source specifics.
From the source
Read at news.google.comUse of GLP-1 Receptor Agonists Increasing Among Children With Obesity